Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Rowe

Showing results (181-190 of 365) with videos related to

Pageof 37
Sort By:
International Journal of Geriatric Psychiatry|April 27, 2016
Amyloid burden and incident depressive symptoms in cognitively normal older adultsKarra D Harrington, Emma Gould, Yen Ying Lim, et al.
Biomedicines|May 28, 2022
Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal StudyKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Journal of Alzheimer'S Disease : JAD|May 16, 2018
Self-Reported Physical Activity is Associated with Tau Burden Measured by Positron Emission TomographyBelinda M Brown, Stephanie R Rainey-Smith, Vincent Dore, et al.
JAMA Psychiatry|January 29, 2015
Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort studyRobert H Pietrzak, Yen Ying Lim, Alexander Neumeister, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 5, 2017
A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE studyVictor L Villemagne, Christopher C Rowe, Kevin J Barnham, et al.
The Medical Journal of Australia|March 16, 2011
Advances in structural and molecular neuroimaging in Alzheimer's diseaseKathryn A Ellis, Christopher C Rowe, Cassandra E I Szoeke, et al.
Neurobiology of Aging|October 6, 2023
Longitudinal trajectories of basal forebrain volume in normal aging and Alzheimer's diseaseYing Xia, Paul Maruff, Vincent Doré, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 30, 2013
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationKeith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, et al.
Stroke|April 12, 2012
Subacute ischemic stroke is associated with focal 11C PiB positron emission tomography retention but not with global neocortical Aβ depositionJohn V Ly, Christopher C Rowe, Victor L Villemagne, et al.
Nuclear Medicine and Biology|April 17, 2012
In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracerMichelle T Fodero-Tavoletti, Damian Brockschnieder, Victor L Villemagne, et al.
Pageof 37

Showing results (181-190 of 365) with videos related to

Sort By:
Pageof 37
International Journal of Geriatric Psychiatry|April 27, 2016
Amyloid burden and incident depressive symptoms in cognitively normal older adultsKarra D Harrington, Emma Gould, Yen Ying Lim, et al.
Biomedicines|May 28, 2022
Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal StudyKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Journal of Alzheimer'S Disease : JAD|May 16, 2018
Self-Reported Physical Activity is Associated with Tau Burden Measured by Positron Emission TomographyBelinda M Brown, Stephanie R Rainey-Smith, Vincent Dore, et al.
JAMA Psychiatry|January 29, 2015
Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort studyRobert H Pietrzak, Yen Ying Lim, Alexander Neumeister, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 5, 2017
A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE studyVictor L Villemagne, Christopher C Rowe, Kevin J Barnham, et al.
The Medical Journal of Australia|March 16, 2011
Advances in structural and molecular neuroimaging in Alzheimer's diseaseKathryn A Ellis, Christopher C Rowe, Cassandra E I Szoeke, et al.
Neurobiology of Aging|October 6, 2023
Longitudinal trajectories of basal forebrain volume in normal aging and Alzheimer's diseaseYing Xia, Paul Maruff, Vincent Doré, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 30, 2013
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationKeith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, et al.
Stroke|April 12, 2012
Subacute ischemic stroke is associated with focal 11C PiB positron emission tomography retention but not with global neocortical Aβ depositionJohn V Ly, Christopher C Rowe, Victor L Villemagne, et al.
Nuclear Medicine and Biology|April 17, 2012
In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracerMichelle T Fodero-Tavoletti, Damian Brockschnieder, Victor L Villemagne, et al.
Pageof 37